Skip to content

Effect of an Advanced Notification Letter on Screening Colonoscopy Participation

Participation in Screening Colonoscopy in Response to an Advanced Notification Letter Plus Standard Invitation Versus Standard Invitation Only - a Population-based Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02188927
Enrollment
6800
Registered
2014-07-14
Start date
2014-08-31
Completion date
2015-02-28
Last updated
2014-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma, Colorectal Cancer, Rectal Cancer

Keywords

Advanced notification letter, Standard invitation, Participation rate, Colonoscopy, Screening, Colorectal Neoplasms, Digestive System Diseases

Brief summary

Participation in a primary screening colonoscopy programs remains low. Advanced notification letter has been shown to increase participation in colorectal cancer screening with fecal occult blood testing and to be cost effective compared to standard invitation. It is unknown whether advanced notification letter increases participation rate in primary colonoscopy screening program. We hypothesize that an Advance Notification Letter will have significant influence on participation in screening colonoscopy, comparing to standard invitation procedure and will thus result in higher efficiency of the program. This randomized controlled study aims to compare the participation rate in screening colonoscopy in response to advanced notification plus standard invitation letter and standard invitation letter alone. Material and methods: 6800 individuals aged 55-64 years will be drawn from the Population Registry and randomly assigned in a 1:1 ratio to the group invited for screening colonoscopy with advanced notification letter (send two weeks before standard invitation) plus standard invitation (send six weeks before planned screening colonoscopy) or to standard invitation only (send six weeks before planned screening colonoscopy). The sample size was calculated to detect 3% difference in participation rate between the groups (25% vs 28%) with 80% power.

Interventions

OTHERImplementation of ANL

Advance Notification Letter will be send two weeks before Standard Invitation for screening colonoscopy

BEHAVIORALNo included ANL

Sending Standard Invitation only six weeks before planned screening colonoscopy

Sponsors

Centre of Postgraduate Medical Education
CollaboratorOTHER
European Union
CollaboratorOTHER
Maria Sklodowska-Curie National Research Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* all individuals aged 55-64 years living in the counties covered with the organized CRC screening program and assigned to invitation to screening colonoscopy in the year 2014 are eligible for the study.

Exclusion criteria

* message from neighbor/family/post office on death of screenee (not updated in Population Registry) * resident abroad (not updated in Population Registry) * return of unopened letter of invitation and/or reminder (address unknown) * diagnosis of CRC before the date of draw (not updated in the National Cancer Registry)

Design outcomes

Primary

MeasureTime frameDescription
Participation ratethree months after receiving invitationA percentage of invitees who undergo the screening colonoscopy. The sample size was calculated to detect 3% difference in participation rate between the groups (25% vs 28%) with 80% power.

Secondary

MeasureTime frameDescription
Response ratethree months after receiving invitationEstimation of the invitees' response rate to Standard Invitation and Advanced Notification Letter followed by Standard Invitation, before receiving Reminding Letter.

Other

MeasureTime frameDescription
Cost of including Advance Notification Letter1 yearTotal cost of including Advanced notification letter into the standard invitation procedure of this study group.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026